Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...

The National Institute for Health and Care Excellence (NICE) has recommended a new oral treatment for men with untreated hormone-relapsed metastatic prostate cancer. NICE assessed evidence from the ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...

Although prostate cancer most often affects elderly men, there are a significant number of cases in men aged 45 to 54 years of age. In 2021, this population accounted for 6% of all cases in the United ...

Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...

Enolen's fast track designation by the FDA highlights its potential to address unmet needs in early-stage prostate cancer treatment. The implant technology aims to deliver high local drug ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

IsoPSA offers a more precise prostate cancer screening by analyzing PSA protein isoforms, reducing false positives compared to traditional PSA tests. Clinical studies show IsoPSA's superior diagnostic ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

It’s not always an easy conversation for men to have, but talking about prostate problems is a critical part of staying healthy. Symptoms such as urinary frequency, urgency, or difficulty going to the ...